Hemogenyx Pharmaceuticals Plc (HOPHF)
Market Closed
7 Aug, 20:00
$
2. 33
0
0%
$
15.84M Market Cap
- P/E Ratio
- Div Yield
25,000 Volume
- Eps
$ 2.33
Previous Close Want to track HOPHF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hemogenyx Pharmaceuticals Plc (HOPHF) Statistics
Valuation metrics
Market Cap 15.84M
Enterprise value 43.6M
Trailing P/E (ttm) -2.87
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) -
Price/Book (mrq) 32.09
Enterprise Value/Revenue -
Enterprise Value/EBITDA -6.83
Overview
Shares outstanding 4.59M
Float 3.62M
Shares short -
% Held by insiders 0.31%
% Held by institutions 0.01%
Average volume (10 days) 3.57K
Average volume (90 days) 3.28K
Price summary
52-Week low 2.33
52-Week high 2.33
Beta 1.54
50-Day moving average 2.33
200-Day moving average 2.33
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:400
Last split Date 13 Dec 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -2.34%
Return on equity -28.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -1.3M
EBITDA -6.75M
Net income to common (ttm) -10.57M
Diluted EPS (ttm) -1.62
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 306.9K
Total cash per share (mrq) 0.26
Total debt (mrq) 2.98M
Total Debt/Equity (mrq) 1.68
Current ratio (mrq) 1.38%
Book value per share (mrq) 0.19
Cash Flow
Cash flow statement -7.54M
Levered free cash flow (LFCF) -1.49M
